Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Ono

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Plos One|July 21, 2012
Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cellsKeisuke Tabara, Rina Kanda, Kahori Sonoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021Mitsuru Yasuda, Satoshi Takahashi, Saori Oba, et al.
The Journal of Biological Chemistry|June 26, 2025
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancerTomohito Tanihara, Yuya Yoshida, Takashi Ogino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Cancer Science|September 13, 2006
High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinomaShinichi Aishima, Yuji Basaki, Yoshinao Oda, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trialCarlota Costa, Miguel Angel Molina, Ana Drozdowskyj, et al.
Nature Chemical Biology|January 16, 2019
Selective and reversible modification of kinase cysteines with chlorofluoroacetamidesNaoya Shindo, Hirokazu Fuchida, Mami Sato, et al.
Ebiomedicine|February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor PrognosisNiki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Plos One|July 21, 2012
Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cellsKeisuke Tabara, Rina Kanda, Kahori Sonoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021Mitsuru Yasuda, Satoshi Takahashi, Saori Oba, et al.
The Journal of Biological Chemistry|June 26, 2025
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancerTomohito Tanihara, Yuya Yoshida, Takashi Ogino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Cancer Science|September 13, 2006
High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinomaShinichi Aishima, Yuji Basaki, Yoshinao Oda, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trialCarlota Costa, Miguel Angel Molina, Ana Drozdowskyj, et al.
Nature Chemical Biology|January 16, 2019
Selective and reversible modification of kinase cysteines with chlorofluoroacetamidesNaoya Shindo, Hirokazu Fuchida, Mami Sato, et al.
Ebiomedicine|February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor PrognosisNiki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Pageof 13